Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FD928
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,747
Award facts
- Contract value 100% obligated
- $15,746.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Otezla 30 mg tablets (60-count) with a contract value of $15,746.65. This firm fixed-price delivery order is unclassified as a set-aside contract and represents a competitive award to the prime contractor. The contract is expected to be completed by November 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders through its IDC with the Defense Logistics Agency to support military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. The Otezla delivery order reflects the company's ongoing role in providing pharmaceutical products to support Department of Defense healthcare requirements. AmerisourceBergen is positioned as a key supplier within DLA's planned Pharmaceutical Prime Vendor Global Program Generation V initiative, which contemplates multiple regional awards to ensure comprehensive pharmaceutical support for Defense Health Agency customers and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FD928?
SPE2DR26FD928 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FD928 worth?
The government has obligated $15,747 on SPE2DR26FD928.
Is contract SPE2DR26FD928 an order under another contract?
Yes. SPE2DR26FD928 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FD928 competed?
The extent of competition for SPE2DR26FD928 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award